TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 21624734

Group type: EXPERIMENTAL
Intervention: Plasma TIMP-4 concentration measured at baseline and 24 weeks
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Plasma TIMP-1, TIMP-2, and TIMP-4 concentrations measured at baseline and 24 weeks
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Plasma TIMP-4 concentration
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Plasma TIMP-2 concentration
Number of subjects: 100
Study: 19699335

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg/day for 2 days
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (immediate PCI)
Number of subjects: 200
Study: 16678497

Group type: EXPERIMENTAL
Intervention: Total Laparoscopic Hysterectomy (TLH)
Number of subjects: 590

Group type: COMPARATOR
Intervention: Total Abdominal Hysterectomy (TAH)
Number of subjects: 590
Study: 15267214

Group type: EXPERIMENTAL
Intervention: Sildenafil
Number of subjects: 280

Group type: COMPARATOR
Intervention: Quinolone
Number of subjects: 280
Study: 11673293

Group type: EXPERIMENTAL
Intervention: Pulsair 3000
Number of subjects: 150

Group type: COMPARATOR
Intervention: Goldmann tonometry
Number of subjects: 150
Study: 10069684

Group type: EXPERIMENTAL
Intervention: 20 mg simvastatin (S)
Number of subjects: 64

Group type: COMPARATOR
Intervention: 200 mg micronized fenofibrate (F)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Both S and F
Number of subjects: 64
Study: 7641018

Group type: EXPERIMENTAL
Intervention: Transanal abdominal transanal radical proctosigmoidectomy with coloanal anastomosis (TATA)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Full-thickness local excision (FTLE)
Number of subjects: 109
Study: 2476978

Group type: EXPERIMENTAL
Intervention: Topical retinoic acid treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 755030

Group type: EXPERIMENTAL
Intervention: Amipaque
Number of subjects: 10

Group type: COMPARATOR
Intervention: Gastrografin
Number of subjects: 10
Study: 31628677

Group type: EXPERIMENTAL
Intervention: Secukinumab 300 mg
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: Secukinumab 150 mg
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: Secukinumab (both doses)
Number of subjects: 233

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 233
Study: 31733759

Group type: EXPERIMENTAL
Intervention: Core strengthening protocol (30-min sessions, twice a week for 5 consecutive weeks)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 18
Study: 28104990

Group type: EXPERIMENTAL
Intervention: Sitagliptin (100 mg daily)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: MRI IDEAL technique
Number of subjects: 12
Study: 26231437

Group type: EXPERIMENTAL
Intervention: Subtotal hysterectomy
Number of subjects: 304

Group type: COMPARATOR
Intervention: Total hysterectomy
Number of subjects: 304
Study: 23521470

Group type: EXPERIMENTAL
Intervention: XPF caps
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: XPF thyroid collars
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard thyroid collars
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: XPF caps and XPF thyroid collars
Number of subjects: 60
Study: 21658524

Group type: EXPERIMENTAL
Intervention: Culturally responsive parent training (PT) program, 14-week intervention
Number of subjects: 54

Group type: COMPARATOR
Intervention: Delayed treatment (wait-list control)
Number of subjects: 54
Study: 19200384

Group type: EXPERIMENTAL
Intervention: 11-month, nurse-delivered, telephone-based intervention
Number of subjects: 250

Group type: COMPARATOR
Intervention: Printed education materials only
Number of subjects: 250
Study: 16766855

Group type: EXPERIMENTAL
Intervention: Imidapril
Number of subjects: 29

Group type: COMPARATOR
Intervention: Nifedipine
Number of subjects: 29
Study: 15329302

Group type: EXPERIMENTAL
Intervention: Neuropsychological assessment prior to smoking cessation treatment (including VSWM and WCST)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Non-psychiatric control smokers (n=40)
Number of subjects: 32
Study: 11748103

Group type: EXPERIMENTAL
Intervention: Hyperthyroidism (H)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Acetylcholine infusion in Hyperthyroidism (H)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Norepinephrine infusion in Hyperthyroidism (H)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: L-NMMA infusion in Hyperthyroidism (H)
Number of subjects: 21
Study: 9029636

Group type: EXPERIMENTAL
Intervention: [U‐13C]18:3 omega 3
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: [U‐13C]18:2 omega 6
Number of subjects: 0
Study: 9662077

Group type: EXPERIMENTAL
Intervention: Duodenal lipid (Intralipid 20%) infusion for 90 minutes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Duodenal lipid (Intralipid 20%) infusion for 45 minutes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Duodenal lipid (Intralipid 20%) infusion for 15 minutes
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline infusion (control)
Number of subjects: 0
Study: 2709366

Group type: EXPERIMENTAL
Intervention: Finger-floss
Number of subjects: 112

Group type: COMPARATOR
Intervention: Brushing-only
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Looped-floss
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Flossholder
Number of subjects: 112
Study: 1257500

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 4

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4
Study: 31078427

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI) for CTO in symptomatic patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: Medical management
Number of subjects: 0
Study: 27922026

Group type: EXPERIMENTAL
Intervention: AspireAssist plus Lifestyle Counseling
Number of subjects: 207

Group type: COMPARATOR
Intervention: Lifestyle Counseling alone
Number of subjects: 207
Study: 26408513

Group type: COMPARATOR
Intervention: Controlled Breathing (CB)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Controlled Breathing with Aromatherapy (IPA)
Number of subjects: 82
Study: 23159721

Group type: EXPERIMENTAL
Intervention: High load (20 sets of 2 repetitions)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Low load (2 sets of 20 repetitions)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Combined (low and high load)
Number of subjects: 32
Study: 21288364

Group type: EXPERIMENTAL
Intervention: Caffeinated coffee (CC)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Decaffeinated coffee (DC)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (no coffee)
Number of subjects: 40
Study: 19392864

Group type: EXPERIMENTAL
Intervention: Dexlansoprazole MR 30 mg
Number of subjects: 947

Group type: EXPERIMENTAL
Intervention: Dexlansoprazole MR 60 mg
Number of subjects: 947

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 947
Study: 16938693

Group type: EXPERIMENTAL
Intervention: STM tasks
Number of subjects: 403

Group type: EXPERIMENTAL
Intervention: WM tasks
Number of subjects: 403
Study: 15707175

Group type: EXPERIMENTAL
Intervention: Biennial screening program using faecal occult blood tests
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Extending the program to include 70 to 74-year-olds
Number of subjects: 0
Study: 11570305

Group type: EXPERIMENTAL
Intervention: Antiplatelet therapy with low-dose acetylsalicylic acid (ASA) initiated within 48 hours of stroke onset
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dedicated care for stroke patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Research into defibrinogenating and neuroprotective agents
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine anticoagulation
Number of subjects: 0
Study: 9250108

Group type: EXPERIMENTAL
Intervention: 1-2% acetylated potato starch
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 2% beta-cyclodextrin starch
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control (native, unmodified potato starch)
Number of subjects: 11
Study: 8323207

Group type: EXPERIMENTAL
Intervention: Oral fluids ad libitum from the first postoperative day (group 1)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Traditional graduated regimen of 30 ml/h for 24 h, 60 ml/h for 24 h, 90 ml/h for 24 h, then free fluids (group 2)
Number of subjects: 60
Study: 3609882

Group type: EXPERIMENTAL
Intervention: Flunarizine (5-10 mg/day, orally in drops)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 30284589

Group type: EXPERIMENTAL
Intervention: Hand hygiene workshop intervention
Number of subjects: 496

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 496
Study: 26861469

Group type: EXPERIMENTAL
Intervention: Nivolumab 0.3 mg/kg
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Nivolumab 2.0 mg/kg
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Nivolumab 10.0 mg/kg
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Nivolumab (all doses)
Number of subjects: 146
Study: 24157251

Group type: EXPERIMENTAL
Intervention: Meridian-marking method
Number of subjects: 0

Group type: COMPARATOR
Intervention: Surgeon's intuition method
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 0
Study: 22522344

Group type: EXPERIMENTAL
Intervention: Mere15 polypeptide
Number of subjects: 1
Study: 22434968

Group type: EXPERIMENTAL
Intervention: Yoga exercise for 50 minutes daily for 4 weeks
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 24
Study: 18765391

Group type: EXPERIMENTAL
Intervention: Trimetazidine
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 15925132

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy for body image concerns
Number of subjects: 41

Group type: COMPARATOR
Intervention: Weight management group
Number of subjects: 41
Study: 12772232

Group type: EXPERIMENTAL
Intervention: Hydrophilic-coated sheath
Number of subjects: 90

Group type: COMPARATOR
Intervention: Uncoated sheath
Number of subjects: 90
Study: 10468724

Group type: EXPERIMENTAL
Intervention: 30 min of transurethral thermotherapy (TUMT)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: 60 min of transurethral thermotherapy (TUMT)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 44
Study: 8983255

Group type: EXPERIMENTAL
Intervention: Amoxycillin
Number of subjects: 442

Group type: EXPERIMENTAL
Intervention: Clarithromycin
Number of subjects: 442
Study: 2006936

Group type: EXPERIMENTAL
Intervention: Surfactant‐TA (modified bovine surfactant extract)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Both groups (Surfactant‐TA and Saline)
Number of subjects: 41
Study: 7102445

Group type: EXPERIMENTAL
Intervention: Preparation stage
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Aversion stage
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Maintenance stage
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Combination of stages
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Booster sessions
Number of subjects: 73

Group type: COMPARATOR
Intervention: All conditions
Number of subjects: 73

Group type: COMPARATOR
Intervention: Follow-up at 12 months
Number of subjects: 73
Study: 31688081

Group type: EXPERIMENTAL
Intervention: Obese/OSAS group
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Nonobese/OSAS and Obese/OSAS groups
Number of subjects: 34
Study: 30876470

Group type: EXPERIMENTAL
Intervention: 180-s exposure to partial-body cryostimulation after training
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control condition (no cryostimulation)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Two 90-s exposures separated by a 5-min rest at room temperature
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 90-s exposure
Number of subjects: 9
Study: 28364452

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT-I)
Number of subjects: 60
Study: 27688021

Group type: EXPERIMENTAL
Intervention: Structured group psychoeducation
Number of subjects: 304

Group type: COMPARATOR
Intervention: Optimised unstructured peer support
Number of subjects: 304
Study: 24572139

Group type: EXPERIMENTAL
Intervention: Exercise and education
Number of subjects: 98

Group type: COMPARATOR
Intervention: Education only
Number of subjects: 98
Study: 22686415

Group type: EXPERIMENTAL
Intervention: n-3 fatty acids (1-g capsule containing at least 900 mg of ethyl esters of n-3 fatty acids daily)
Number of subjects: 12536
Study: 19478198

Group type: EXPERIMENTAL
Intervention: Saxagliptin 2.5 mg plus metformin
Number of subjects: 743

Group type: EXPERIMENTAL
Intervention: Saxagliptin 5 mg plus metformin
Number of subjects: 743

Group type: EXPERIMENTAL
Intervention: Saxagliptin 10 mg plus metformin
Number of subjects: 743

Group type: EXPERIMENTAL
Intervention: Saxagliptin (2.5, 5, and 10 mg) plus metformin
Number of subjects: 743

Group type: COMPARATOR
Intervention: Placebo plus metformin
Number of subjects: 743
Study: 17192326

Group type: EXPERIMENTAL
Intervention: Enhanced therapy (infrared skin thermometer to measure temperatures on six foot sites daily)
Number of subjects: 173

Group type: COMPARATOR
Intervention: Standard therapy (therapeutic footwear, diabetic foot education, regular foot care)
Number of subjects: 173

Group type: COMPARATOR
Intervention: Structured foot examination (daily structured foot inspection and logbook)
Number of subjects: 173
Study: 15193553

Group type: EXPERIMENTAL
Intervention: Damped DILE (dynamic impact-loading exercise)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Nondamped DILE
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 24
Study: 11164324

Group type: EXPERIMENTAL
Intervention: Psychological intervention including assessment and a personalized program with realistic manageable goals for lifestyle change and overcoming barriers using brief motivational interviewing.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care control group
Number of subjects: 0
Study: 9725760

Group type: EXPERIMENTAL
Intervention: IV ASA medication
Number of subjects: 25
Study: 8054075

Group type: EXPERIMENTAL
Intervention: Eccentric arm work
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Concentric leg exercise
Number of subjects: 14
Study: 2608542

Group type: EXPERIMENTAL
Intervention: Educational (experimental) group
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 36
Study: 4616805

Group type: EXPERIMENTAL
Intervention: Chlormethiazole
Number of subjects: 38

Group type: COMPARATOR
Intervention: Dichloralphenazone
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 31128924

Group type: EXPERIMENTAL
Intervention: Antiplatelet therapy
Number of subjects: 537

Group type: COMPARATOR
Intervention: Avoid antiplatelet therapy
Number of subjects: 537
Study: 28735829

Group type: EXPERIMENTAL
Intervention: Pilates Mat Group (PMG)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Equipment Based Pilates Group (PAG)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 98
Study: 25354720

Group type: EXPERIMENTAL
Intervention: Zoledronic acid 4 mg intravenously every 4 weeks for up to 24 months, combined with bicalutamide 80 mg orally every day and goserelin acetate 10.8 mg subcutaneously every 12 weeks.
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Zoledronic acid combined with androgen-deprivation therapy.
Number of subjects: 53
Study: 24643488

Group type: EXPERIMENTAL
Intervention: 14 contacts with a promotora (community health worker), consisting of 11 home visits and three telephone calls
Number of subjects: 361

Group type: EXPERIMENTAL
Intervention: 14 contacts with a promotora (community health worker)
Number of subjects: 361

Group type: COMPARATOR
Intervention: Delayed treatment intervention
Number of subjects: 361
Study: 21983612

Group type: EXPERIMENTAL
Intervention: Toothpastes with natural compounds
Number of subjects: 56
Study: 18459180

Group type: EXPERIMENTAL
Intervention: Primary chemotherapy
Number of subjects: 48

Group type: COMPARATOR
Intervention: Whole-brain radiotherapy (WBRT)
Number of subjects: 48
Study: 16441247

Group type: EXPERIMENTAL
Intervention: Short-term AED therapy (6 months)
Number of subjects: 206

Group type: COMPARATOR
Intervention: Long-term AED therapy (2 years)
Number of subjects: 206
Study: 14967268

Group type: EXPERIMENTAL
Intervention: Round-edged optic IOL
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Sharp-edged optic IOL
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Angulated IOLs
Number of subjects: 71

Group type: COMPARATOR
Intervention: Nonangulated silicone IOL
Number of subjects: 71
Study: 11384687

Group type: EXPERIMENTAL
Intervention: Vasopressin 10 units/10 mL of normal saline
Number of subjects: 51

Group type: COMPARATOR
Intervention: Normal saline (placebo) 10 mL
Number of subjects: 51
Study: 9401425

Group type: EXPERIMENTAL
Intervention: Tone that differed from preceding stimuli in the conjunction of two features
Number of subjects: 0

Group type: COMPARATOR
Intervention: Preceding stimuli with different combinations of features
Number of subjects: 0
Study: 8427657

Group type: EXPERIMENTAL
Intervention: High salt diet (342 mmol NaCl/day)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Low salt diet (34 mmol NaCl/day)
Number of subjects: 14
Study: 3309050

Group type: EXPERIMENTAL
Intervention: Relaxation response elicitation (20 minutes per day until surgery)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Reading (20 minutes per day)
Number of subjects: 49
Study: 30454034

Group type: EXPERIMENTAL
Intervention: Forced Air Warming (FAW)
Number of subjects: 8630

Group type: COMPARATOR
Intervention: Resistive Fabric Warming (RFW)
Number of subjects: 8630
Study: 28662957

Group type: EXPERIMENTAL
Intervention: Direct Anterior Approach (DAA)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Posterolateral Approach (PLA)
Number of subjects: 120
Study: 26193978

Group type: EXPERIMENTAL
Intervention: Vonoprazan 20 mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Esomeprazole 20 mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Rabeprazole 10 mg
Number of subjects: 20
Study: 23431213

Group type: EXPERIMENTAL
Intervention: McKenzie method
Number of subjects: 148

Group type: COMPARATOR
Intervention: Back School method
Number of subjects: 148
Study: 21939510

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg bid for two weeks
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo for two weeks
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg bid
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 18312764

Group type: EXPERIMENTAL
Intervention: fluvastatin XL 80 mg/day
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: ezetimibe 10 mg/day
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: fluvastatin XL 80 mg/day plus ezetimibe 10 mg/day
Number of subjects: 199
Study: 16361021

Group type: EXPERIMENTAL
Intervention: Dexanabinol (150 mg intravenous dose within 6 hours of injury)
Number of subjects: 861

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 861

Group type: EXPERIMENTAL
Intervention: Dexanabinol
Number of subjects: 861
Study: 12540407

Group type: EXPERIMENTAL
Intervention: scFOS treatment
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: scFOS treatment (subgroup >6 years postmenopause)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo treatment (subgroup >6 years postmenopause)
Number of subjects: 12
Study: 11046201

Group type: EXPERIMENTAL
Intervention: Haemaccel-Ringer's prime
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Plasmalyte 148
Number of subjects: 22
Study: 8677723

Group type: EXPERIMENTAL
Intervention: Nifedipine (20-60 mg daily, usually 30-40 mg)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 21
Study: 1522841

Group type: COMPARATOR
Intervention: Standard-dose epinephrine (0.02 mg/kg)
Number of subjects: 1280

Group type: EXPERIMENTAL
Intervention: High-dose epinephrine (0.2 mg/kg)
Number of subjects: 1280
Study: 6430605

Group type: EXPERIMENTAL
Intervention: Mestranol 24 micrograms daily
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 16
Study: 30499871

Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine
Number of subjects: 180

Group type: COMPARATOR
Intervention: Intravenous ketamine
Number of subjects: 180

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 180
Study: 29862494

Group type: EXPERIMENTAL
Intervention: VHA's Quality Enhancement Research Initiative and Health Services Research and Development Service program evaluations
Number of subjects: 0
Study: 27075674

Group type: EXPERIMENTAL
Intervention: Mometasone furoate
Number of subjects: 176

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 176
Study: 25268962

Group type: EXPERIMENTAL
Intervention: Current PPI use (within 90 days)
Number of subjects: 1830

Group type: EXPERIMENTAL
Intervention: Current PPI use among patients receiving diuretics
Number of subjects: 1830

Group type: EXPERIMENTAL
Intervention: Current PPI use among patients not receiving diuretics
Number of subjects: 1830

Group type: COMPARATOR
Intervention: Histamine H2 receptor antagonists
Number of subjects: 1830
Study: 22427558

Group type: EXPERIMENTAL
Intervention: Training in the use of closed-circuit television (CCTV) combined with delivery instructions
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Closed-circuit television (CCTV)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Control group (delivery instructions only)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: CCTV usage over time
Number of subjects: 122
Study: 20931799

Group type: EXPERIMENTAL
Intervention: GnRH antagonist started when leading follicle reached 14mm
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: GnRH antagonist started when leading follicle reached 16mm
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group without GnRH antagonist
Number of subjects: 90
Study: 16987898

Group type: EXPERIMENTAL
Intervention: Combined photodynamic therapy (PDT) with intravitreal triamcinolone (IVTA)
Number of subjects: 22

Group type: COMPARATOR
Intervention: PDT monotherapy
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Combined PDT with IVTA
Number of subjects: 22